Mkts

Puma Biotechnology Inc

NASDAQ: PBYI
$7.22+0.08 (+1.12%)
As of Nov 18, 4:00 PM ET

Key statistics

Day range
7.017.36
52-week range
4.8011.50
Today
Open7.15
Previous close7.22
Volume—
Valuation
Market cap369.64M
P/E ratio13.84×
EPS (TTM)0.52
Income & risk
Dividend / yield—
Beta1.49
Avg volume360.2K
Discussion

PBYI News

Stories mentioning PBYI from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue44,81475,45354,47552,43646,00759,07780,54247,083
Cost of Goods Sold10,42423,12712,17312,30110,55613,92129,09710,658
Gross Profit34,39052,32642,30240,13535,45145,15651,44536,425
Operating Expenses
Research & Development
Sales General & Admin18,42318,37916,81718,04717,60416,62216,81924,972
Total Operating Expenses
Operating Income (Loss)(3,828)17,1069,5736,6363,98413,36522,079(2,179)
Interest Income1,002977.001,044956.001,1011,2261,2821,244
Interest Expense
Other Expense130.00143.00115.00410.00359.00268.00347.00156.00
Pretax Income(3,427)17,1079,2436,1653,26712,23820,608(4,151)
Tax Provision(7,067)291.00378.00
Net Income (Loss)(3,753)13,4388,8445,8552,97419,30520,317(4,529)
Earnings Per Share (Basic)(0.07)0.270.180.120.060.400.41(0.09)
Earnings Per Share (Diluted)(0.07)0.270.170.120.060.390.41(0.09)
Weighted Average Shares Outstanding (Basic)50,84550,01150,33949,70049,59648,64949,00848,292
Weighted Average Shares Outstanding (Diluted)50,84550,65350,93050,14549,90649,10049,17348,292

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About PBYI

Puma Biotechnology Inc (NASDAQ: PBYI) is a stock listed on the Nasdaq Stock Market under the ticker symbol PBYI. It last traded at $7.22 (Nov 18, 2026, 4:00 PM ET), up 1.1% on the day. That gives Puma Biotechnology a market capitalisation of $369.6M and a price-to-earnings ratio of 13.8.

Over the past 52 weeks PBYI has traded between $4.80 and $11.50.

Revenue for the quarter ended Mar 31, 2026 was $44.8M; a net loss of $3.8M. Revenue was down 2.6% from $46.0M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$44.8M-$3.8M-8.4%
Dec 31, 2025$75.5M$13.4M17.8%
Sep 30, 2025$54.5M$8.8M16.2%
Jun 30, 2025$52.4M$5.9M11.2%

From Puma Biotechnology’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…